Verily, Alphabet's life sciences unit, found it more challenging than expected to measure glucose levels in tears. Especially once it started testing its device outside of the lab. » Read More
By: Angelica LaVito
Pfizer deferred planned drug price increases this summer after President Donald Trump criticized the drug giant on Twitter. » Read More |
By: Waverly Colville
Tesaro shares soared 39 percent Friday upon a Bloomberg report that the pharmaceutical company will explore the opportunity of a sale. » Read More |
By: Meg Tirrell
BioMarin's clinical trial of a gene therapy for hemophilia is providing hope to patients with the disease. It is an experimental treatment that uses a virus to deliver a healthy copy of a gene to make up for one that causes excessive bleeding. » Read More |
Gottlieb rolled out new rules Thursday restricting retail sales of most flavored e-cigarettes mostly to vape shops and other stores that don't allow minors. Most convenience stores and gas stations will effectively be banned.
Facebook CFO David Wehner is one of three new board members appointed to Alector, a company taking an innovative approach to curing Alzheimer's. The other two are 23andMe's chief science officer, Richard Scheller, and ex-Genentech CFO Louis Lavigne.
Food and Drug Administration Commissioner Scott Gottlieb outlined a slew of policies, including restrictions on sales of flavored e-cigarettes, and essentially threatened to pull products from the market if manufacturers do not follow them.
Obamacare sign-ups on the federal health insurance marketplace fell by 20 percent in the first two weeks of this enrollment season compared to last year, according to new federal data.
UnitedHealthcare members enrolled in the Motion program can get an Apple Watch for the cost of taxes and shipping alone, if they reach certain fitness milestones.
DeepMind Health says that it will be absorbed into Google Health, but it still won't be sharing patient health information with its parent company. Its critics remain concerned.
Health insurance start-up Oscar Health sued Florida Blue, accusing the independent licensee of the Blue Cross and Blue Shield Association of using inappropriate practices that allow it to be a monopoly in the state's Obamacare market.
Juul's new e-cigarette policy doesn't go as far as expected. A person briefed on the company's plan told CNBC last week that Juul would stop all retail sales of flavored nicotine pods. There was no mention of resuming sales at any point.
CNBC has learned that DeepMind's health subsidiary is moving under the newly-formed Google Health led by former Geisinger CEO David Feinberg.
Only 26 percent of men, 19 percent of women and 20 percent of adolescents meet the U.S. Department of Health and Human Services' guidelines for physical activity.
Fontem Ventures, a unit of tobacco company Imperial Brands, says it will raise the minimum age requirements to buy nicotine pods on its website to 21 regardless of where consumers are shopping.
Amarin CEO is defending results from a major clinical trial of its Vascepa heart drug after researchers raise questions about early results that sent stocks up in September.
FDA Commissioner Dr. Scott Gottlieb plans to announce this week the agency will move forward with a ban on menthol cigarettes, senior FDA officials told CNBC last week.
Analyst Scott Davis says Danaher, which GE's Larry Culp once ran, would "love" to own the life sciences business of GE Healthcare.
In 2012, Quanttus set out to make a smart watch that could measure blood pressure around the clock. It failed but the dream lives on, as Quanttus alums spread out to companies like Apple, Alphabet, Amazon, Fitbit, Nike, Samsung and more.
Google is hoping to better coordinate its efforts in health care. It hired Geisinger Health CEO's David Feinberg, but in the interim, it has named Verily's Linus Upson as interim chief.
Get the best of CNBC in your inbox
Data also provided by 
